from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3139/fadE24

LFCtreatmentdescriptionclass of inhibitor

2.166

Amikacinug/mL Amikacintranslation

2.117

Cap5-10ug/mL Capreomycintranslation

2.183

Rox10-50 ug/mL Roxithromycintranslation

-0.106

SM2-5 ug/mL Streptomycintranslation

1.679

Tet5-10 ug/mL Tetracyclinetranslation

-1.112

Rif0.2-5ug/mL Rifampicintranscription

0.196

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.306

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.148

CPZ10-50 ug/mL Chlorpromazinerespiration

0.731

Clofazimine10-13 ug/mL Clofaziminerespiration

0.076

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.906

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.702

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.767

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.476

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.051

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.853

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.315

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.238

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.268

Nigericin50 uM Nigericinrespiration

0.443

TRC10-150 ug/mL Triclosanrespiration

0.372

TRZ10-25 ug/mL Thioridazinerespiration

-0.528

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.612

menadione6-10 ug/mL Menadionerespiration

-0.015

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.095

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.775

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.134

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.381

NRP_1Non-replicating persistence stage 1dosRassociated

-0.059

Amp0.2mg/mL AmpicillincellWall

0.129

Cephalexin20-100 ug/mL CephalexincellWall

-0.458

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.320

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.290

EMB10-20 ug/mL EthambutolcellWall

2.595

Eta12-40 ug/mL EthionamidecellWall

2.157

INH0.2-0.4 ug/mL IsoniazidcellWall

1.970

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.566

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.201

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.822

BZA0.12 mg/mL BenzamidearomaticAmides

-0.656

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.796

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.755

H2O24 mM hydrogen peroxideDNAdamaging

0.210

Levo10 ug/mL LevofloxacinDNAdamaging

-0.768

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.475

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.270

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.266

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.019

Antimycin12.5-50 ug/mL Antimycin A?

-0.249

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.479

PA_110-50 ug/mL Antitubercular compound PA-1?

0.453

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.189

PA8240.2-2 ug/mL PA-824?

1.316

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.171

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.007

Verapamil50 uM Verapamil?

0.555

mercaptoethanol2 mM 2-Mercaptoethanol?

0.308

methoxatin10-20 ug/mL Methoxatin?